When analyzing the induced pluripotent stem cell (iPSC) market, the technical aspects can often appear to be confusing. However, if you focus on a few key points of understanding, you’ll be able to understand key attributes that define the cell type, as well as their advantages and disadvantages. [Read more…]
BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market
BOTHELL, Wash. and Cambridge, UK, February 12, 2026 —BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces it has entered into a multi-year supply agreement with Qkine Limited under which BioLife will distribute certain cytokine and growth factor products manufactured by Qkine for use in cell and gene therapy manufacturing. [Read more…]
MEDIPOST Surpasses 330,000 Cord Blood Units Amid $140M Funding Boost
In January 2026, MEDIPOST Inc., the U.S. affiliate of South Korea‑based regenerative medicine and biotechnology company MEDIPOST Co., Ltd., successfully closed a $140 million funding round aimed at accelerating late-stage clinical development and operational growth. This capital infusion was led by Skylake Equity Partners and Crescendo Equity Partners, with participation from a leading Korean growth equity fund. The funds are intended to support MEDIPOST’s anticipated Phase III clinical trial of its allogeneic, umbilical cord blood-derived mesenchymal stem cell therapy for symptomatic cartilage defects in knee osteoarthritis, as well as expansion of its scientific, manufacturing, and infrastructure capabilities. [Read more…]
TriHaz Solutions Opens New Chattanooga, Tennessee Facility to Expand Regulated Medical Waste Services Across the Southeast
Chattanooga, TN – February 17, 2026 – TriHaz Solutions, a trusted provider of regulated medical waste management, is proud to announce the opening of a new operational facility located at 4120 S Creek Rd, Chattanooga, TN 37406. This expansion strengthens TriHaz’s ability to serve healthcare facilities, laboratories, and clinical operations throughout Chattanooga and surrounding Tennessee markets with reliable and fully compliant medical waste disposal services. [Read more…]
The Cost Of Stem Cell Therapy in 2026
How much is stem cell therapy today in 2026? According to analysis by BioInformant, the cost of stem cell therapy ranges from less than $5,000 for simple procedures to $25,000 or more for complex ones. In general, stem cell treatment procedures are paid out-of-pocket by patients, because they are not covered by medical insurance. The cost of platelet rich therapy (PRP), which can be used separately or in conjunction with stem cell therapy, is typically $500-700, but may be as high as $2,000 at some locations. [Read more…]
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 336
- Next Page »




